Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports


The Bio Implants Market shall be growing unabatedly in the future. The healthcare vertical is expected to go “personalized” in the next 10 years. Thus, genomics and genetics, along with the other biologic information, going personalized will help in early diagnosis of the disease and also how patients will respond to the treatments. Likewise, the healthcare vertical would be there to make greater strides in the forecast period.

Bio-implants are bioengineered products made up of biosynthetic materials such as collagen and tissue-engineered products like artificial skin and tissue. Bio-implants are used in organ transplantation and replacement of tissues. Bio-implants find application in cardiovascular, orthopedic, neurological, dental, and other areas.

Increasing aging population is one of the key factors driving the bio-implants market owing to the fact that aged people are more susceptible to chronic diseases, such as cardiovascular diseases, orthopedic disorders, endovascular diseases, and dental disorders.

Bio-implants are mainly classified into biological implants, biologised implants, and biofunctionalized implants. Biological implants include cell therapy, bioartificial organs, and tissue engineering. Biologised implants comprise technical implants, biohybrid systems and in-vivo cell lining. Biofunctionalized implants include drug eluting stents and surface functionalized implants.

Get Sample Copy of this Report@

The global bio-implants market is categorized on the basis of type, origin, materials, and end users. Based on type, this market is segmented into cardiovascular implants, spinal implants, orthopedics and trauma, dental implants, ophthalmic implants, neurostimulators implants, and other implants. Cardiovascular implants include pacing devices, stents and related implants, and structural cardiac implants.

Orthopedics and trauma implants comprise reconstructive joint replacements, orthobiologics, trauma implants, and sports medicine. Dental implants include plate form dental implants and root form dental implants.

Ophthalmic implants comprise intraocular lens and glaucoma implants. Neurostimulator implants are further categorized as deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, vagus nerve stimulators, and other neurostimulation. Other implants include gynecological devices, drug implants, otolaryngeal implants, cosmetic implants, gastroenterological implants, urological implants, and skin and wound care implants.

Based on origin, the market is further sub-segmented into allograft, autograft, xenograft, and synthetic origins. Based on materials, the market covers ceramics, biomaterial metals, alloys, polymers, and biological materials. Based on end user, this market is segmented into medical device manufacturing companies, pharmaceutical companies, research institutes, and academic institutes.

Request for Table of Content@

North America has the largest market for bio-implants, followed by Europe. This is due to growing aging population, technological advancement, rise in awareness about cosmetic implants, rising demand for nonsurgical bio-implants, increasing prevalence of chronic diseases, increasing health care expenditure, rise in patient population, and improved healthcare infrastructure in the region.

The bio-implants market in Asia is expected to experience a high growth rate in the next few years due to developing healthcare infrastructures, increasing prevalence of chronic diseases, rising disposable income, and growing aging population in the region.

In addition, increasing population and growth in economies in developing countries, such as India and China, is expected to drive the bio-implants market in Asia.

These factors, along with broadening application areas of bio-implants, are expected to drive the global market for bio-implants. However, high cost of implants and reimbursement issues are some of the factors that inhibit the growth of the market.

Access Full Report@

Increasing number of mergers and acquisitions, rising number of collaborations and partnerships, new product launches, and increasing research and development activities are some of the latest trends that have been observed in the global bio-implants market. The major companies operating in this market worldwide are Synthes, Inc., Abbott Laboratories, Biomet, Inc., Boston Scientific Corporation, C.R. Bard, Inc., Endo Health Solutions, Inc., LifeNet Health, Inc., Orthofix International N.V., Stryker Corporation, W.L. Gore & Associates, Inc., Smith & Nephew Plc, and Biotronik SE & Co. KG.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353

Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700

Sales –
Website –

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts